BIOTECH RALLIES The promise of new cancer therapies coming out of last week’s American Society of Clinical Oncology meeting in […]

Financial Snapshot For May 2003: Yee Hah The biotech sector has turned in a remarkable performance this year – especially

BIOTECH TEMPERATURE RISES Investors are showing classic symptoms of biotech fever. They’re seizing on good news about drug trials, cheering

Biotech is benign Europe’s continued blocking of GM imports is illegal, unjustified and founded on ignorance.

Science and Law: Swapping the lab for the law For scientists who want a career in law, the options are

Biotech sector keeps surging / Cancer drug news and FDA approvals create optimism Industry observers say the sector’s sea change

Early stage biotechnology collaborations The range of deals an early stage biotechnology company may enter into is wide (see box

FDA chief looks to speed diabetes, obesity drugs Mark McClellan, commissioner of the Food and Drug Administration, said he wants

Pfizer sues over counterfeit Lipitor Pfizer Inc. said Tuesday it was suing two companies connected to counterfeit versions of its

The ImClone Story: A Hyped Drug, a Tainted Icon It was, in retrospect, a festival of hype emblematic of the